| Recommendation for Adult Immunization |
|---|
Age: How often: | All 10 years |
Note: Vaccine variations exist: DTaP (for young children), DT (for children who cannot have the pertussis component), Tdap (once for everyone), Td (every 10 years), TT (tetanus toxoid for people who cannot have any diphtheria component) Pediatrics: - Children receive 5 doses of the DTaP (diphtheria and tetanus toxoids and acellular pertussis) vaccine. (This DTaP replaced the older DTP.) The preferred schedule is 1st dose at 2 months of age, 2nd dose at 4 months of age, 3rd dose at 6 months of age, 4th dose at 15-18 months of age, and the last dose at 4-6 years of age. For catch-up pediatric dosing, please see CDC recommendations. The DTaP variation is not licensed for anyone 7 years of age or older.
Adults and older children: - The vaccine variation Tdap is recommended once for everyone age 11-64 years, in place of one routine Td immunization. Tdap and Td have reduced strengths of diphtheria; Tdap also has reduced strength pertussis.
- For catch-up adult dosing, see the CDC recommendations and note that if an adult missed the childhood DTaP they will need a Tdap series.
|
Available brands of this vaccine include:
- Boostrix® (Tdap for ages 10-18)
- AdacelTM (Tdap for ages 11-64)
- Daptacel® (DTaP)
- Infanrix® (DTaP)
- Tripedia® (DTaP)
- TriHIBit® (DTaP combined with Haemophilus influenza vaccine)
- Pediarix® (DTaP combined with Hepatitis B vaccine and inactivated poliovirus vaccine)
- DT (pediatric diphtheria and tetanus vaccine without pertussis)
- DECAVAC® (adult tetanus, diphtheria booster vaccine)
- TT (tetanus vaccine booster)
1. What is this vaccine?
The DTaP is a vaccine against diseases caused by 3 different bacteria: diphtheria (Corynebacterium diphtheriae), tetanus (Clostridium tetani), and pertussis (Bordatella pertussis). The vaccine is made from sterile diphtheria and tetanus toxoids (modified toxins that are non-toxic) and 3 different pertussis antigens; there are no live bacteria in this vaccine. The Td is a diphtheria and tetanus booster for adults. The Tdap is a one-time booster containing the Td components plus the acellular petussis. The Tdap would also be used for adult catch-up series. The TT is a tetanus vaccine without diphtheria or pertussis vaccine components.
2. Why is this vaccine important?
This vaccine can prevent the diseases caused by 3 different bacteria. Diphtheria infects the throat and can lead to breathing problems, paralysis, and death. Tetanus, also called lockjaw, can cause tightening of muscles all over the body, inability to open the mouth, and death. Pertussis infection, also called whooping cough, causes terrible coughing, pneumonia, and even death.
3. How is this vaccine given?
The DTaP vaccine is given into the muscle of the anterolateral thigh or deltoid. The Tdap is given into the deltoid muscle. The Td vaccine is given into the muscle of the mid-thigh laterally or into the deltoid.
4. What are the risks and special considerations of this vaccine?
DTaP: This vaccine is not recommended for those who have had a serious reaction to a prior DTaP dose or those who had a brain or nervous system illness (such as high fever, seizure, or prolonged crying) within 7 days of a prior dose. Some people with these kinds of problems may be advised to get just the DT component of the vaccine, and omit the acellular pertussis component.
After the DTaP shot, fever and/or redness, swelling, or soreness at the injection site may develop. This is more common after the 4th and 5th doses. Fussiness, fatigue, and vomiting may also occur. More serious problems are less likely. These can include seizures, crying for greater than 3 hours, or high fever over 105 degrees Fahrenheit. Very rarely there have been cases of severe allergic reaction, ongoing seizure disorder, and brain damage. It is recommended that children with a history of seizures be treated with an aspirin-free pain reliever at the time of the shot and for 24 hours afterwards. Report any serious reactions to your doctor immediately.
Tdap: This vaccine is not recommended for those who have had a serious reaction to any component of the vaccine or any related vaccine. If you have a history of coma or seizures after a DTP or DTaP, the vaccine is not recommended unless it is clear that there was another cause of the problem. People with other nervous system diseases may not be able to get the vaccine. Safety has not been proven in pregnancy, although it is under evaluation. Check with your doctor if you are breastfeeding.
After the Tdap shot mild reactions like pain, soreness, or swelling at the injection site may occur. In some cases low-grade fever, headache, fatigue, nausea, vomiting, diarrhea, chills, aches, or rash may also occur. Rarely symptoms at the injection site and more severe systemic symptoms may develop. Severe reactions including nervous system reactions should be reported immediately.
Td: This vaccine is not recommended for those who have had a serious reaction to it or to another diphtheria or tetanus vaccine. It is preferred that women be vaccinated when not pregnant. Safety in pregnancy is not proven, but this vaccine can be given in pregnacy if necessary. Talk to your doctor. Also, check with your doctor if you are breastfeeding.
Mild reactions to the Td include soreness, swelling, or redness at the injection site. This could be worse if the vaccine is given very often. Serious allergic reactions are rare. Painful muscle wasting of the arm or arms may start 2 days to 4 weeks after the vaccine, but is very rare.
Individuals with prior severe reactions to this vaccine may not be able to receive another dose. Check with your doctor regarding this issue and for any other contraindications for this vaccine. Also check with your doctor to find out what other ingredients may be in the vaccine, its container, or any diluent in case of allergies or other concerns. Immunization is usually postponed for individuals with a moderate or severe acute illness.
5. Risk factors for contraction of disease
- For diphtheria: non-immune patient with crowded environment and poor hygiene
- For tetanus: non-immune patient with open wounds, especially obtained outdoors and when wound was in contact with soil
- For pertussis: non-immune patient; before vaccines most cases were in infants and small children, but now more is seen in teenagers and adults
Citations
- "Recommended Immunization Schedule for Persons Aged 0-18 Years, United States 2008." U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. May 2008. http://www.cdc.gov/vaccines/recs/schedules/downloads/child/2008/08_11x17_booklet_pr.pdf.
- "Recommended Adult Immunization Schedule — United States, October 2007–September 2008." U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. October 2007. www.cdc.gov/mmwr/pdf/wk/mm5641-Immunization.pdf.
- "Diphtheria, Tentanus, & Pertussis Vaccines: What You Need to Know." U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. National Immunization Program Vaccine Information Statement. May 2007. http://www.immunize.org/vis/dtap01.pdf.
- "Tetanus, Diphtheria Pertussis (Tdap) Vaccine: What You Need to Know." U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. National Immunization Program Vaccine Information Statement. July 2006. http://www.immunize.org/vis/Tdap.pdf.
- "Tetanus and Diphtheria Vaccine (Td)." U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. June 1994. http://www.immunize.org/vis/td2.pdf.
- "Diphtheria." Medline Plus. A Service of the U.S. National Library of Medicine and the National Institutes of Health. September 2006. http://www.nlm.nih.gov/medlineplus/ency/article/001608.htm.
- "Tetanus." Medline Plus. A Service of the U.S. National Library of Medicine and the National Institutes of Health. November 2006. http://www.nlm.nih.gov/medlineplus/ency/article/000615.htm.
- "Pertussis." Medline Plus. A Service of the U.S. National Library of Medicine and the National Institutes of Health. October 2007. http://www.nlm.nih.gov/medlineplus/ency/article/001561.htm.
- "Infanrix® Diphtheria and Tetanus Toxoids and Acellular Pertuss Vaccine Adsorbed." (DTaP) GlaxoSmithKline. March 2008. http://us.gsk.com/products/assets/us_infanrix.pdf.
- "Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Tripedia®." (DTaP) Aventis Pasteur. September 2000. http://www.fda.gov/CBER/label/dtapave030701LB.pdf.
- "Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Daptacel®." Aventis Pasteur. March 2008. http://www.fda.gov/CBER/label/daptacelLB.pdf.
- "Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed ADACELTM." Sanofi Pasteur. March 2008. http://www.fda.gov/CbER/label/adacelLB.pdf.
- "Boostrix® (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed)." GlaxoSmithKline. April 2008. http://us.gsk.com/products/assets/us_boostrix.pdf.
- "Tetanus and Diphtheria Toxoids Adsorbed for Adult Use DECAVACTM." (Td) Aventis Pasteur. March 2004. http://www.fda.gov/Cber/label/tdtave032404LB.pdf.
- "Tetanus Toxoid Adsorbed USP." Aventis Pasteur Inc. July 2005. http://www.fda.gov/cber/label/ttoxave092305LB.pdf.
- "PEDIARIX® [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) abd Inactivated Poliovirus Vaccine Combined]." GlaxoSmithKline. June 2007. http://us.gsk.com/products/assets/us_pediarix.pdf.
- "Vaccine Excipient and Media Summary." U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/appendices/B/excipient-table-1.pdf.
- "Vaccine Excipient and Media Summary, Part 2." U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. April 2008. http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/appendices/B/excipient-table-2.pdf.
- "Thimerosol in Vaccines." U.S. Food and Drug Administration. Center for Biologics Evaluation and Research. June 2007. http://www.fda.gov/cber/vaccine/thimerosal.htm.
Created: 7/2/2007
Last Modified: 8/12/2008